Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.33
-0.31 (-2.45%)
At close: May 29, 2026, 4:00 PM EDT
12.25
-0.08 (-0.65%)
After-hours: May 29, 2026, 7:59 PM EDT

TNXP Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-147.39-124.02-130.04-116.66-110.22-92.29
Depreciation & Amortization
1.991.933.424.291.250.05
Stock-Based Compensation
7.116.024.789.2810.917.9
Other Adjustments
0.455.8555.141.12-3
Change in Receivables
-5.54-2.62-3.68---
Changes in Inventories
3.821.733.740.06--
Changes in Accounts Payable
4.882.990.93-3.49-1.053.53
Changes in Accrued Expenses
12.6311.751.191.791.211.75
Changes in Other Operating Activities
-6.78-3.463.61.61-0.160.51
Operating Cash Flow
-125.58-99.84-60.93-102-98.05-75.56
Capital Expenditures
-5.06-3.37-0.12-7.9-48.15-35.31
Sale of Property, Plant & Equipment
---1--
Payments for Business Acquisitions
----22.17--
Other Investing Activities
-1.01-1.16----
Investing Cash Flow
-6.21-4.53-0.12-29.07-48.15-35.31
Long-Term Debt Issued
---8.94--
Long-Term Debt Repaid
--9.65-2.35---
Net Long-Term Debt Issued (Repaid)
--9.65-2.358.94--
Issuance of Common Stock
220.08237.94140.2241.5494.5212.49
Repurchase of Common Stock
-10.71-13.76--13.97--
Net Common Stock Issued (Repurchased)
209.37224.18140.2227.5894.5212.49
Issuance of Preferred Stock
----40.59-
Repurchase of Preferred Stock
-----47.25-
Net Preferred Stock Issued (Repurchased)
-----6.66-
Other Financing Activities
---3---
Financing Cash Flow
185.2214.53134.8736.5287.84212.49
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.02-0.030-0.07-0.07-0.03
Net Cash Flow
53.39110.1373.83-94.62-58.43101.59
Free Cash Flow
-130.64-103.21-61.05-109.9-146.2-110.86
FCF Margin
-744.12%-787.47%-604.76%-1414.75%--
Free Cash Flow Per Share
-12.51-12.13-82.90-13867.30-80089.70-194715.00
Levered Free Cash Flow
-135.9-122.11-119.63-111.36-163.77-121.76
Unlevered Free Cash Flow
-139.7-114.15-123.94-122.02-158.99-121.79
SEC Filings: 10-K · 10-Q